482 related articles for article (PubMed ID: 1321277)
1. Transforming properties and substrate specificities of the protein tyrosine kinase oncogenes ros and src and their recombinants.
Jong SM; Zong CS; Dorai T; Wang LH
J Virol; 1992 Aug; 66(8):4909-18. PubMed ID: 1321277
[TBL] [Abstract][Full Text] [Related]
2. Matrix-independent activation of phosphatidylinositol 3-kinase, Stat3, and cyclin A-associated Cdk2 Is essential for anchorage-independent growth of v-Ros-transformed chicken embryo fibroblasts.
Uttamsingh S; Zong CS; Wang LH
J Biol Chem; 2003 May; 278(21):18798-810. PubMed ID: 12646574
[TBL] [Abstract][Full Text] [Related]
3. Role of gag sequence in the biochemical properties and transforming activity of the avian sarcoma virus UR2-encoded gag-ros fusion protein.
Jong SM; Wang LH
J Virol; 1990 Dec; 64(12):5997-6009. PubMed ID: 2173777
[TBL] [Abstract][Full Text] [Related]
4. Molecular and biochemical bases for activation of the transforming potential of the proto-oncogene c-ros.
Zong CS; Poon B; Chen J; Wang LH
J Virol; 1993 Nov; 67(11):6453-62. PubMed ID: 8411348
[TBL] [Abstract][Full Text] [Related]
5. Most of the substrates of oncogenic viral tyrosine protein kinases can be phosphorylated by cellular tyrosine protein kinases in normal cells.
Kamps MP; Sefton BM
Oncogene Res; 1988 Sep; 3(2):105-15. PubMed ID: 2465525
[TBL] [Abstract][Full Text] [Related]
6. A mutation in v-src that removes a single conserved residue in the SH-2 domain of pp60v-src restricts transformation in a host-dependent manner.
Verderame MF; Kaplan JM; Varmus HE
J Virol; 1989 Jan; 63(1):338-48. PubMed ID: 2462061
[TBL] [Abstract][Full Text] [Related]
7. Molecular cloning and characterization of avian sarcoma virus UR2 and comparison of its transforming sequence with those of other avian sarcoma viruses.
Neckameyer WS; Wang LH
J Virol; 1984 Jun; 50(3):914-21. PubMed ID: 6328022
[TBL] [Abstract][Full Text] [Related]
8. Enhancement of transforming potential of human insulinlike growth factor 1 receptor by N-terminal truncation and fusion to avian sarcoma virus UR2 gag sequence.
Liu D; Rutter WJ; Wang LH
J Virol; 1992 Jan; 66(1):374-85. PubMed ID: 1309253
[TBL] [Abstract][Full Text] [Related]
9. Cloning and characterization of a thermolabile v-src gene for use in reversible transformation of mammalian cells.
Maroney AC; Qureshi SA; Foster DA; Brugge JS
Oncogene; 1992 Jun; 7(6):1207-14. PubMed ID: 1375718
[TBL] [Abstract][Full Text] [Related]
10. Reduced phosphotyrosine binding by the v-Src SH2 domain is compatible with wild-type transformation.
Tian M; Martin GS
Oncogene; 1996 Feb; 12(4):727-34. PubMed ID: 8632894
[TBL] [Abstract][Full Text] [Related]
11. A glycoprotein in the plasma membrane matrix as a major potential substrate of p60v-src.
Hamaguchi M; Matsuda M; Hanafusa H
Mol Cell Biol; 1990 Feb; 10(2):830-6. PubMed ID: 2153925
[TBL] [Abstract][Full Text] [Related]
12. Intracellular targeting of pp60src expression: localization of v-src to adhesion plaques is sufficient to transform chicken embryo fibroblasts.
Liebl EC; Martin GS
Oncogene; 1992 Dec; 7(12):2417-28. PubMed ID: 1334249
[TBL] [Abstract][Full Text] [Related]
13. The transforming protein P68gag-ros of avian sarcoma virus UR2 is a transmembrane protein with the gag portion protruding extracellularly.
Jong SM; Wang LH
Oncogene Res; 1987 Jun; 1(1):7-21. PubMed ID: 2835728
[TBL] [Abstract][Full Text] [Related]
14. A retroviral promoter is sufficient to convert proto-src to a transforming gene that is distinct from the src gene of Rous sarcoma virus.
Zhou H; Duesberg PH
Proc Natl Acad Sci U S A; 1990 Dec; 87(23):9128-32. PubMed ID: 2174554
[TBL] [Abstract][Full Text] [Related]
15. pp60src-dependent protein phosphorylation in membranes from Rous sarcoma virus-transformed chicken embryo fibroblasts.
Dehazya P; Martin GS
Virology; 1985 Jun; 143(2):407-21. PubMed ID: 2998019
[TBL] [Abstract][Full Text] [Related]
16. Rous sarcoma virus variants that encode src proteins with an altered carboxy terminus are defective for cellular transformation.
Wilkerson VW; Bryant DL; Parsons JT
J Virol; 1985 Aug; 55(2):314-21. PubMed ID: 2991557
[TBL] [Abstract][Full Text] [Related]
17. Two point mutations in the transmembrane domain of P68gag-ros inactive its transforming activity and cause a delay in membrane association.
Jong SM; Wang LH
J Virol; 1991 Jan; 65(1):180-9. PubMed ID: 1845883
[TBL] [Abstract][Full Text] [Related]
18. Avian sarcoma virus UR2 encodes a transforming protein which is associated with a unique protein kinase activity.
Feldman RA; Wang LH; Hanafusa H; Balduzzi PC
J Virol; 1982 Apr; 42(1):228-36. PubMed ID: 6177870
[TBL] [Abstract][Full Text] [Related]
19. Specific inhibition of tyrosine kinase activity by an antibody to the v-ros oncogene product.
Balduzzi PC; Chovav M; Christensen JR; Macara IG
J Virol; 1986 Nov; 60(2):765-7. PubMed ID: 2430110
[TBL] [Abstract][Full Text] [Related]
20. A noncatalytic domain conserved among cytoplasmic protein-tyrosine kinases modifies the kinase function and transforming activity of Fujinami sarcoma virus P130gag-fps.
Sadowski I; Stone JC; Pawson T
Mol Cell Biol; 1986 Dec; 6(12):4396-408. PubMed ID: 3025655
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
